Practically in India if a “X” company patented invention is not available at an affordable price to the public at large after two years from the grant date, section 85 of the Indian Patent Act can be invoked to grant compulsory licence.
Therefore, the onus to avoid revocation in India is with the patent assignee to develop methodology to keep the price of medicines cost effective and make it available to the general public.